MoneyWorks4Me

JFL Life Sciences - Quaterly Results

19 May 2025 Evaluate
The Sales for the quarter ended March 2025 of Rs. 117.32 million declined by -45.94% from Rs. 217.01 millions.Net profit was down at Rs. 0.83  millions against Rs. 11.93 millions recorded in the corresponding quarter a year ago.The net profit spiraled down by -93.04%.Operating profit for the quarter ended March 2025 decreased to 13.76 millions as compared to 15.65 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 117.32 217.01 -45.94 820.42 465.48 76.25 820.42 465.48 76.25
Other Income 0.01 0.20 -95.00 0.10 5.14 -98.05 0.10 5.14 -98.05
PBIDT 13.76 15.65 -12.08 82.09 50.95 61.12 82.09 50.95 61.12
Interest 3.32 0.87 281.61 10.81 8.60 25.70 10.81 8.60 25.70
PBDT 10.44 14.78 -29.36 71.28 42.35 68.31 71.28 42.35 68.31
Depreciation 3.55 1.07 231.78 9.93 4.43 124.15 9.93 4.43 124.15
PBT 6.89 13.71 -49.74 61.35 37.92 61.79 61.35 37.92 61.79
TAX 6.06 1.78 240.45 19.77 4.92 301.83 19.77 4.92 301.83
Deferred Tax 4.12 -1.10 -474.55 4.49 -3.03 -248.18 4.49 -3.03 -248.18
PAT 0.83 11.93 -93.04 41.58 33.00 26.00 41.58 33.00 26.00
Equity 329.95 110.00 199.95 329.95 110.00 199.95 329.95 110.00 199.95
PBIDTM(%) 11.73 7.21 62.64 10.01 10.95 -8.59 10.01 10.95 -8.59
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..